# CVS HEALTH CORPORATION (CVS) FY2024 Q3 P&L / Income Statement

- Company: CVS HEALTH CORPORATION (CVS)
- Period: 2024-07-01 to 2024-09-30
- Filing: Q3 FY2024 10-Q, filed 2024-11-06, accession number 0000064803-24-000034
- Page: https://plicit.ai/financials/cvs/fy2024-q3-income-statement
- Chart image: https://plicit.ai/charts/cvs-fy2024-q3-income-statement-sankey.png

## Chart details: Revenue by Product and Service

Income statement for 2024-07-01 through 2024-09-30. View: Revenue categories. Revenue uses this breakdown; costs and expenses retain the consolidated categories.

- **Total revenues**: 95,428,000,000 US dollars
- **Total operating costs**: 94,596,000,000 US dollars
- **Operating income**: 832,000,000 US dollars
- **Other income (expense), net (calculated)**: negative 727,000,000 US dollars
- **Income before income tax provision**: 105,000,000 US dollars
- **Income tax provision**: 34,000,000 US dollars
- **Net income**: 71,000,000 US dollars
- **Products**: 59,674,000,000 US dollars
- **Services**: 4,279,000,000 US dollars
- **Premiums**: 30,925,000,000 US dollars
- **Net investment income**: 550,000,000 US dollars
- **Cost of products sold**: 52,948,000,000 US dollars
- **Health care costs**: 29,922,000,000 US dollars
- **Operating expenses**: 10,557,000,000 US dollars
- **Restructuring charges**: 1,169,000,000 US dollars
- **Loss on assets held for sale**: 0 US dollars

### Chart connections

- Revenue minus operating expenses equals operating income.
- Operating income plus other income or expense equals income before tax. Income before tax less income tax expense or benefit equals net income.
- Of which attributable to CVS HEALTH CORPORATION: $87.00 M; to noncontrolling interests: −$16.00 M.

## Chart details: Revenue by Business Segment

- Page: https://plicit.ai/financials/cvs/fy2024-q3-income-statement/revenue-by-business-segment
- Chart image: https://plicit.ai/charts/cvs-fy2024-q3-revenue-by-business-segment-sankey.png

Income statement for 2024-07-01 through 2024-09-30. View: Business segment. Revenue uses this breakdown; costs and expenses retain the consolidated categories.

- **Total revenues**: 95,428,000,000 US dollars
- **Total operating costs**: 94,596,000,000 US dollars
- **Operating income**: 832,000,000 US dollars
- **Other income (expense), net (calculated)**: negative 727,000,000 US dollars
- **Income before income tax provision**: 105,000,000 US dollars
- **Income tax provision**: 34,000,000 US dollars
- **Net income**: 71,000,000 US dollars
- **Health Care Benefits**: 32,996,000,000 US dollars
- **Health Services**: 44,129,000,000 US dollars
- **Pharmacy & Consumer Wellness**: 32,423,000,000 US dollars
- **Cost of products sold**: 52,948,000,000 US dollars
- **Health care costs**: 29,922,000,000 US dollars
- **Operating expenses**: 10,557,000,000 US dollars
- **Restructuring charges**: 1,169,000,000 US dollars
- **Loss on assets held for sale**: 0 US dollars
- **Revenue before reconciliation (calculated)**: 109,548,000,000 US dollars. Sum of the reported revenue categories before the separately reported reconciliation.
- **Intersegment Eliminations**: negative 14,262,000,000 US dollars. Reported reconciliation to consolidated revenue.
- **Corporate/ Other**: 142,000,000 US dollars. Reported reconciliation to consolidated revenue.

### Chart connections

- Revenue minus operating expenses equals operating income.
- Operating income plus other income or expense equals income before tax. Income before tax less income tax expense or benefit equals net income.
- Reported revenue categories plus the separately reported signed reconciliation equals consolidated revenue.
- Of which attributable to CVS HEALTH CORPORATION: $87.00 M; to noncontrolling interests: −$16.00 M.